Pleural Effusion: Causes, Thoracentesis, and How to Prevent Recurrence

Pleural Effusion: Causes, Thoracentesis, and How to Prevent Recurrence

20 February 2026 · 0 Comments

When fluid builds up around your lungs, it doesn’t just make breathing harder-it can signal something serious. This buildup, called pleural effusion, isn’t a disease on its own. It’s a symptom. And if you’re struggling to catch your breath, especially when lying down or moving, this might be why.

What Causes Pleural Effusion?

Not all fluid around the lungs is the same. Doctors split it into two types: transudative and exudative. The difference tells you what’s really going on inside your body.

Transudative effusions happen when pressure or protein levels in your blood get out of balance. The most common cause? Congestive heart failure. About half of all pleural effusions come from this. When your heart can’t pump well, fluid backs up and leaks into the space around your lungs. Liver disease (cirrhosis) and kidney problems (nephrotic syndrome) can do the same thing. These are slow leaks, often linked to long-term conditions.

Exudative effusions are more urgent. They happen when something is inflaming or damaging the pleura-the thin lining around your lungs. Pneumonia is the top culprit, causing 40-50% of these cases. Cancer is next, responsible for 25-30%. That’s why doctors take this seriously: if you have an exudative effusion, you might have an infection, a tumor, or a blood clot in the lung (pulmonary embolism). Tuberculosis still shows up in some areas, especially where it’s common.

The key to figuring out which type you have? Light’s criteria. Developed in 1972, it’s still the gold standard. If your pleural fluid has a protein ratio over 0.5, LDH over 0.6 compared to blood, or LDH higher than two-thirds of the normal blood level-it’s exudative. These numbers don’t lie. And if your fluid pH is below 7.2, glucose under 60 mg/dL, or LDH over 1000 IU/L, you’re likely dealing with a complicated infection or cancer.

How Thoracentesis Works

If fluid is building up and you’re short of breath, doctors don’t just wait. They drain it. That’s thoracentesis. It’s a simple procedure, but it’s not something you do without guidance.

Ultrasound is now required. Before ultrasound, up to 19% of patients got a collapsed lung (pneumothorax) after the procedure. Now? That risk drops to under 5%. The ultrasound shows exactly where the fluid is, how much there is, and avoids hitting the lung or blood vessels. The needle or catheter goes in between the ribs, usually at the 5th to 7th space along the side of your chest. You’re sitting up, leaning forward. It takes less than 15 minutes.

For diagnosis, they take 50-100 mL. For relief, they can safely remove up to 1500 mL in one go. But they don’t always drain it all. Too much too fast can cause re-expansion pulmonary edema-a rare but dangerous swelling of the lungs after they suddenly refill with air. That’s why some doctors now use pleural manometry: they measure pressure as they drain. If it stays under 15 cm H₂O, the risk of complications drops to less than 5%.

The fluid gets tested. Protein, LDH, cell count, pH, glucose, and cytology (looking for cancer cells). Cytology finds cancer in about 60% of malignant cases. If glucose is low or pH is acidic, it points to an infection. High amylase? Could mean pancreatitis. Blood in the fluid? Might be a pulmonary embolism or trauma.

Complications happen in 10-30% of cases without ultrasound. With it? Down to 4-6%. Pneumothorax is still the biggest risk, followed by bleeding and infection. But with proper technique, serious problems are rare.

Contrasting causes of pleural effusion: heart failure leaking fluid and cancer spreading in lung tissue.

Why You Can’t Just Drain and Walk Away

Draining fluid feels better. But if you don’t fix what caused it, the fluid comes back. Fast.

For heart failure? The fix isn’t drainage-it’s medication. Diuretics like furosemide, ACE inhibitors, beta-blockers. When doctors use NT-pro-BNP levels to guide treatment, recurrence drops from 40% to under 15% in three months. Drain the fluid, but also treat the heart.

For pneumonia? Antibiotics are the priority. If the fluid is thick, cloudy, or has a pH under 7.2 or glucose under 40 mg/dL, you need drainage. Left untreated, 30-40% of these turn into empyema-pus in the chest. That requires surgery.

Now, the toughest one: cancer. Malignant pleural effusion has a 50% chance of coming back within 30 days after a single drainage. That’s why doctors don’t stop at thoracentesis. They go further.

Preventing Recurrence: What Actually Works

The goal isn’t just to remove fluid. It’s to stop it from coming back. And the best method depends entirely on the cause.

For cancer patients, two options dominate: pleurodesis and indwelling pleural catheters.

Pleurodesis means sticking the lung to the chest wall. Talc slurry is the most common. It causes inflammation that fuses the layers together. Success? 70-90%. But it’s painful. About 60-80% of patients need strong pain meds afterward. Hospital stay? Usually 3-7 days.

Indwelling pleural catheters (IPC) are changing the game. A small tube stays in place, usually for weeks. You drain it at home, a few times a week. No hospital stay. Less pain. Better quality of life. Success rate? 85-90% at six months. A 2021 study in the New England Journal of Medicine showed patients using IPCs went home in 2.1 days instead of 7.2. That’s huge.

The American Thoracic Society now recommends IPCs as first-line for malignant effusions, especially if the lung is trapped or the patient has limited life expectancy. Talc is still good, but it’s no longer the only choice.

For post-surgery effusions-common after heart bypass-most clear up on their own. But if more than 500 mL drains per day for three days straight, they keep the chest tube in. That prevents recurrence in 95% of cases.

And here’s the catch: don’t drain small, silent effusions. A 2019 JAMA Internal Medicine study found 30% of thoracentesis procedures on small, asymptomatic effusions gave no benefit. No diagnosis. No relief. Just risk.

A cancer patient managing pleural effusion at home with an indwelling catheter, enjoying improved daily life.

What Experts Are Saying

Dr. Richard Light, who created the criteria we still use today, put it bluntly: “Treating the effusion without treating the cause is like bailing water from a sinking boat without patching the hole.”

Today’s approach is smarter. It’s not about removing fluid. It’s about identifying the source and matching the treatment. A 2023 Yale Medicine study showed that tailoring treatment to cancer type and patient health dropped recurrence from 50% to just 15%. That’s not luck. That’s precision medicine.

Ultrasound isn’t optional anymore. It’s the standard. And personalized plans-based on fluid chemistry, patient symptoms, and underlying disease-are now the norm. The future isn’t just more procedures. It’s fewer, smarter ones.

What You Need to Remember

- If you have unexplained shortness of breath, get checked. Don’t assume it’s just aging or asthma.

- Not all fluid around the lungs is the same. The type tells you the cause.

- Ultrasound-guided thoracentesis is safer, faster, and more accurate. Always insist on it.

- Drainage alone won’t stop recurrence. The cause must be treated.

- For cancer-related effusions, indwelling catheters offer better quality of life than repeated hospital visits.

- Don’t drain small, asymptomatic effusions. It does more harm than good.

The bottom line? Pleural effusion isn’t just a fluid problem. It’s a warning sign. And how you respond to it makes all the difference.

Benjamin Vig
Benjamin Vig

I am a pharmaceutical specialist working in both research and clinical practice. I enjoy sharing insights from recent breakthroughs in medications and how they impact patient care. My work often involves reviewing supplement efficacy and exploring trends in disease management. My goal is to make complex pharmaceutical topics accessible to everyone.

Similar posts